Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
23
ARVN Quote, Financials, Valuation and Earnings
Last price:
$7.77
Seasonality move
:
-16.08%
Day range:
$7.35 - $7.66
52-week range:
$5.90 - $33.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.28x
P/B ratio:
0.84x
Volume:
1.7M
Avg. volume:
1.9M
1-year change:
-76.81%
Market cap:
$554M
Revenue:
$263.4M
EPS (TTM):
-$0.66
Earnings Data
Next earnings date for ARVN
Jul 30
2025
Most recent earnings per share
$1.14
Beat by $2.11
(May 1/2025)
Consensus Estimate
-$0.97
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ARVN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $37.1M | -- | -- | -$0.84 | -- |
| 07/30/2025 | Q2 | $34.4M | -- | -- | -$0.89 | -- |
| 05/01/2025 | Q1 | $41.9M | $188.8M | $1.14 | -$0.97 | $2.11 |
| 02/11/2025 | Q4 | $62.8M | $59.2M | -$0.63 | -$0.96 | $0.33 |
| 10/30/2024 | Q3 | $62.4M | $102.4M | -$0.68 | -$0.87 | $0.19 |
| 07/30/2024 | Q2 | $73.6M | $76.5M | -$0.49 | -$0.59 | $0.10 |
| 05/03/2024 | Q1 | $32.1M | $25.3M | -$0.97 | -$1.38 | $0.41 |
| 02/27/2024 | Q4 | $49.3M | -$43.1M | -$2.53 | -$1.23 | -$1.30 |
| 11/07/2023 | Q3 | $40.1M | $34.6M | -$1.18 | -$1.58 | $0.40 |
| 08/08/2023 | Q2 | $31M | $54.5M | -$1.25 | -$1.61 | $0.36 |
| 05/05/2023 | Q1 | $27.7M | $32.5M | -$1.54 | -$1.49 | -$0.05 |
| 02/23/2023 | Q4 | -- | $37.8M | -$1.56 | -- | -- |
| 11/09/2022 | Q3 | -- | $33.2M | -$1.24 | -- | -- |
| 08/04/2022 | Q2 | -- | $33.8M | -$1.32 | -- | -- |
| 05/05/2022 | Q1 | -- | $26.5M | -$1.20 | -- | -- |
| 03/01/2022 | Q4 | -- | $33.2M | -$1.00 | -- | -- |
| 11/03/2021 | Q3 | -- | $9.3M | -$0.94 | -- | -- |
| 08/05/2021 | Q2 | -- | $5.5M | -$1.03 | -- | -- |
| 05/04/2021 | Q1 | -- | $5.5M | -$0.84 | -- | -- |
| 03/01/2021 | Q4 | -- | $6.3M | -$0.99 | -- | -- |
| 11/05/2020 | Q3 | -- | $7.6M | -$0.79 | -- | -- |
| 08/04/2020 | Q2 | -- | $5.7M | -$0.65 | -- | -- |
| 04/28/2020 | Q1 | -- | $6.2M | -$0.56 | -- | -- |
| 03/16/2020 | Q4 | -- | $4.9M | -$0.56 | -- | -- |
| 11/04/2019 | Q3 | -- | $30.1M | -$0.54 | -- | -- |
| 08/05/2019 | Q2 | -- | $4M | -$0.55 | -- | -- |
| 05/08/2019 | Q1 | -- | $4M | -$0.46 | -- | -- |
| 03/26/2019 | Q4 | -- | $3.4M | -$0.52 | -- | -- |
| 09/30/2018 | Q3 | -- | $3.4M | -$3.90 | -- | -- |
| 06/30/2018 | Q2 | -- | $3.4M | -$0.73 | -- | -- |
| 03/31/2018 | Q1 | -- | $4.1M | -$3.65 | -- | -- |
| 12/31/2017 | Q4 | -- | $2.6M | -$0.45 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.7M | -$0.31 | -- | -- |
Arvinas Earnings Questions
-
How Much did Arvinas Generate in Revenue Last Quarter?
Arvinas reported $188.8M worth of top line sales in its most recent quarter.
-
Did Arvinas Beat Earnings Last Quarter?
Arvinas announced earnings per share of $1.14 which represents a beat of analyst forecast a -$0.97 per share.
-
Is Arvinas Profitable?
Arvinas reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Arvinas EPS Next Year?
Arvinas's earnings are forecast to decrease from -$2.77 per share to -$3.10 per share next year representing a decrease of -48.54%.
-
When is Arvinas's Earnings Date?
Arvinas's next earnings date is July 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
